The Patient Centricity & Engagement Conference

20 JUNE 2024 | LONDON

Take Direct Action To Boost Patient Outcomes & Quality Of Life Through Innovative, Collaborative Partnerships With Advocacy Groups & Truly Centring The Patient Voice At The Heart Of Decision Making For

Advanced, Impactful & Value-Adding Strategies For Patient Centricity, Engagement & Partnerships

The Patient Centricity & Engagement Conference | 20 June 2024 | London

08.30 Registration, Informal Networking & GIC Opening Remarks

09.00  Morning Chair’s Opening Remarks

Gunnar Schroefel, Global Director Patient Advocacy, Daiichi Sankyo

Patients At The Heart Of Decision Making

09.10 Centre The Patient At The Heart Of All Decision Making & Take Patient Centricity From Theory To Direct, Meaningful Action

    • Actions speak louder than words! What direct steps can industry take to drive patient centricity and embed the patient at the heart of their organisation?
    • It’s not just about collaboration, it’s about partnering, listening and understanding. When working together is key to joined-up experiences for patients, how can industry strategically collaborate across healthcare to demonstrably boost patient experiences?
    • What corporate strategies approaches showcase the holistic value of patient centricity and truly secure long-term buy-in?

Shannon Altimari, Senior Director, Patient Engagement, Global Oncology Lead, GSK

How Authentic Patient Journeys Create Unparalleled Stakeholder-Engagement & Unlock Greater Collaboration & Value-Capture

09.30 Bonus Session – Reserved For FIXING US

    • Demonstrating how authentic patient journeys are proven mechanisms for bringing together medical, compliance and commercial teams within Pharma organisations
    • Increasing engagement and collaboration between global teams and local markets
    • Helping patients, patient groups and charities to be more empowered, and healthcare professionals and health system stakeholders to be measurably more patient-centric

Anthony Whitington, CEO, FIXING US

Gold Standard Pharma Advocacy Collaboration - Double Perspective

09.45 Develop Meaningful & Impactful Relationships Between Industry & Advocacy Groups For Powerful Partnerships That Deliver Deep Impact For Patients

    • It’s an age-old question, but what does ‘good’ really look like? Determine the key strategies and collaborative processes between pharma and PAGs that ensure long-term success and impact?
    • Align objectives between pharma and advocacy groups to ensure that engagement and centricity programmes are delivering what patients truly need
    • With different advocacy groups having different needs, how best can industry support PAGs in a targeted, personalised manner?

09.45 Sujan Sivasubramaniyam, Head of Medical Affairs & Patient Advocacy, UK & Ireland, CSL Behring

Jefferson Courtney, Policy & Public Affairs Manager, The Haemophilia Society

10.05 Gabor Purman MD, MBA, Patient Advocacy Director, Kyowa Kirin International

WANT TO VIEW THE FULL PROGRAMME?

At Global Insight Conferences, we have exciting offers and news about our upcoming events that we hope you’d like to hear about! We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details of our privacy policy here. You can stop receiving our updates at any time.

Don't Miss Out!

Book Before Thursday & Save £170!